Renata Bezerra de Albuquerque Cavalcante Reis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Renata Bezerra de Albuquerque Cavalcante Reis has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Cesar Vieira DE Sales
Universidade Federal de Pernambuco, Brazil
2 shared publications - Danyelly Bruneska Gondim Martins
Universidade Federal de Pernambuco (UFPE), Instituto Keizo Asami, Mestrado em Gestão Pública para o Desenvolvimento do Nordeste / CCSA / UFPE, Recife, Pernambuco, Brasil image/svg+xml
2 shared publications - Fabrício Oliveira Souto
Keizo Asami Institute, Federal University of Pernambuco
2 shared publications - Isaura Isabelle Fonseca Gomes da Silva
Universidade Federal de Pernambuco, Brasil; Instituto Keizo Asami, Brasil
2 shared publications - José Luiz de Lima Filho
Universidade Federal de Pernambuco (UFPE)
2 shared publications - Leandro de Lima Coutinho
Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA
2 shared publications
Latest Publications
- Open Access
miRNA-195 expression in the tumor tissues of female Brazilian breast cancer patients with operable disease
This study aimed to assess miRNA-195 expression in the tumor tissues from a cohort of Brazilian female breast cancer patients undergoing neoadjuvant chemotherapy (NAC) and evaluate its correlation with various clinicopathological markers.Quantitative ...
Open AccessmiRNA-195 expression in the tumor tissues of female Brazilian breast cancer patients with operable disease
This study aimed to assess miRNA-195 expression in the tumor tissues from a cohort of Brazilian female breast cancer patients undergoing neoadjuvant chemotherapy (NAC) and evaluate its correlation with various clinicopathological markers.Quantitative ...
- Open Access
- 1 October 2020
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 12, 141-151
Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
Introduction: MicroRNA-21 (miRNA-21) has been described as one of the most significantly upregulated miRNAs in human breast cancer. However, limited knowledge exists on miRNA-21 expression in breast cancer tissue after neoadjuvant chemotherapy (NAC). Purpose: The aim of this study was to assess miRNA-21 expression in the tumor tissues of Brazilian patients with breast cancer who underwent NAC and its correlation with clinicopathological variables. Patients and Methods: Utilizing qRT-PCR, miRNA-21 expression in tumor tissue was measured in a cohort of female patients with breast cancer who underwent NAC. The correlation of miRNA-21 expression with breast cancer molecular subtypes and other clinicopathological variables was also assessed. Results: A total of 55 patients were included in the study, and 28 (50.9%) underwent NAC. miRNA-21 was upregulated in patients with breast cancer, regardless of previous exposure to chemotherapy, molecular subtypes, tumor-node-metastasis (TNM) staging and lymph node status of the axilla. miRNA-21 expression did not differ between patients with breast cancer who achieved a pathologic complete response after NAC and healthy controls. Conclusion: miRNA-21 was upregulated in the tumor tissue of Brazilian patients with breast cancer regardless of NAC treatment, which reinforces its role as an “oncomiR” and a potential biomarker.
- 1 October 2020
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 12, 141-151
Open AccessMirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
Introduction: MicroRNA-21 (miRNA-21) has been described as one of the most significantly upregulated miRNAs in human breast cancer. However, limited knowledge exists on miRNA-21 expression in breast cancer tissue after neoadjuvant chemotherapy (NAC). Purpose: The aim of this study was to assess miRNA-21 expression in the tumor tissues of Brazilian patients with breast cancer who underwent NAC and its correlation with clinicopathological variables. Patients and Methods: Utilizing qRT-PCR, miRNA-21 expression in tumor tissue was measured in a cohort of female patients with breast cancer who underwent NAC. The correlation of miRNA-21 expression with breast cancer molecular subtypes and other clinicopathological variables was also assessed. Results: A total of 55 patients were included in the study, and 28 (50.9%) underwent NAC. miRNA-21 was upregulated in patients with breast cancer, regardless of previous exposure to chemotherapy, molecular subtypes, tumor-node-metastasis (TNM) staging and lymph node status of the axilla. miRNA-21 expression did not differ between patients with breast cancer who achieved a pathologic complete response after NAC and healthy controls. Conclusion: miRNA-21 was upregulated in the tumor tissue of Brazilian patients with breast cancer regardless of NAC treatment, which reinforces its role as an “oncomiR” and a potential biomarker.